Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome

Faculty Medicine Year: 2016
Type of Publication: ZU Hosted Pages:
Authors:
Amarallah Abdelmoneim Mohamed Sayed
Journal: Journal of Cancer Research and Therapeutics Published by Wolters Kluwer - Medknow Volume:
Keywords : Genomic aberrations , non- small cell lung cancer    
Abstract:
ABSTRACT The therapeutic options of nonsmall cell lung cancer (NSCLC) therapy has been changed since the first discovery of activating epidermal growth factor receptor (EGFR) mutations and the development of specific EGFR tyrosine kinase
   
     
 
       

Author Related Publications

  • Amarallah Abdelmoneim Mohamed Sayed, "Myelodysplastic syndrome from theoretical review to clinical application view", PAGEPress, Italy, 2018 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Patterns of Inpatient Admissions during Haj Clinical conditions, length of stay and patient outcomes at an advanced care centre in Makkah, Saudi Arabia", Pak J Med Sci, 2018 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Neoadjuvant Platinum and Gemcitabine Regimens Precede Definitive Radiotherapy in Locally Advanced Bladder Cancer", Symbiosis, 2019 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Efficacy and Safety of First-Line Pazopanib in Patients with Metastatic Renal Cell Carcinoma: Real-Life Multi Institutional Experience", Remedy Publications LLC, 2019 More
  • Amarallah Abdelmoneim Mohamed Sayed, "?Aggressive Care at the End of Life; Where Are We", Wolters Kluwer - Medknow, 2019 More

Department Related Publications

  • Adel Salah Bakry, "Assessment of Chemotherapy Induced Ovarian Failure Using Serum Anti￾Mullerian Hormone in Premenopausal Breast Cancer Patients", Zagazig University, Faculty of Medicine, 2024 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed", Springer, 2016 More
  • Ola Mohamed Ahmed Elfarargy, ": Prevalence of Androgen Receptors expression in Triple Negative Breast Cancer Patients and its Correlation with Clinicopathological Criteria: Our Institutes experience", abs/10.1200/JCO.2017.35.15_suppl.e1258, 2017 More
  • Rasha Mohamed Mostafa Hagag, "Factors Affecting Survival in Egyptian Patients Suffering from Urinary Bladder Cancer: A Multicenter Retrospective Study", Journal of Cancer Science & Therapy, 2018 More
  • Rasha Mohamed Mostafa Hagag, "Assessment of initial real life experience with Abiraterone Acetate in patients with castrate resistant prostate cancer: A retrospective study in Saudi Arabian patients", International Journal of Advanced Researc h, 2015 More
Tweet